Immune reconstitution is often impaired for months to years in patients undergoing allogeneic hematopoietic cell transplantation (HCT) and predisposes them to a wide variety of bacterial, viral and fungal infections.
Primary herpes simplex virus (HSV) types 1 and 2 infections in immune-competent hosts most often lead to long-term latent infections and can be associated with recurrent reactivations. HSV-1 is responsible for the majority of nonendemic cases of viral encephalitis, accounts for 10-20% of the 20 000 annual viral encephalitis cases in the United States and is the most common cause of fatal sporadic encephalitis. 1 Symptomatic HSV-1 reactivation after allogeneic HCT predominantly presents as involvement of the oropharyngeal, esophageal or tracheobronchial tracts.
2 Encephalitis due to HSV has not been previously reported in HCT recipients. We present a classical case of herpes simplex encephalitis (HSE) in an allogeneic HCT recipient and highlight the characteristic clinical and diagnostic features of this potentially fatal, but treatable post-transplant infectious disease.
A 63-year-old man had received a nonmyeloablative unrelated umbilical cord blood transplant in November 2006 for high-risk acute myeloid leukemia. Transplant conditioning regimen included fludarabine, cyclophosphamide and total body irradiation (200 cGy); cyclosporine and mycophenolate mofetil were given for prophylaxis against graft-versus-host disease. 3 He was seropositive for HSV before transplantation. Restaging workup at 2-years post-HCT in November 2008 showed complete remission with 100% donor engraftment.
He had extensive skin and gastrointestinal chronic graftversus-host disease that was treated with prednisone and mycophenolate mofetil. /l with 51% lymphocytes and 39% neutrophils, hemoglobin was 12.9 g/100 ml and platelet count was 155 Â 10 9 /l. Peripheral blood flow cytometry showed an absolute CD4 count of 1348 cells/mm 3 , absolute CD8 cell count of 1452 cells/mm 3 and an absolute natural killer cell count of 2177 cells/mm 3 . Total immunoglobulin level was 1130 mg per 100 ml. Chemistry panel and liver function tests were within normal limits.
A computed tomography scan of the head showed no abnormalities. This was followed by magnetic resonance imaging of the brain, which revealed restricted diffusion and increased T2 hyperintensity of the left temporal lobe and was highly suspicious for HSE (Figure 1 cerebrospinal fluid (CSF) examination, which showed protein level of 57 mg per 100 ml (normal, 15-60 mg per 100 ml), glucose level of 46 mg per 100 ml (normal, 40-70 mg per 100 ml), white cell count of 55/ul (82% neutrophils, 4% lymphocytes and 13% monocytes) and red blood cell count of 9/ul. CSF was positive for HSV by polymerase chain reaction. Additional CSF evaluations for infections were negative. Electroencephalogram was also consistent with HSE ( Figure 2) .
He was started empirically on ceftriaxone and high-dose intravenous acyclovir (10 mg/kg every 8 h), followed by acyclovir only once the diagnosis of HSE was confirmed. His fever and anomia improved significantly over the next 4-5 days, and he was discharged on oral valacyclovir to complete a 14-day course of antiviral therapy.
Neurological findings suggestive of involvement of the frontotemporal lobe of the brain along with fever are pathognomonic for HSE. This frontotemporal involvement often manifests itself as personality changes, ataxia, aphasia and focal seizures. These changes are frequently accompanied by nonspecific signs and symptoms of meningoencephalitis such as headache and neck stiffness. CSF findings include elevations in protein concentration along with lymphocytic pleocytosis. Presence of low CSF glucose is very uncommon, and if present, should raise the possibility of an alternative diagnosis. Computed tomography scan of the brain is often normal in the first few days. Encephalogram often shows periodic sharp and slow wave complexes localized to the frontotemporal area of the brain. These encephalogram changes, although nonspecific, occur in 480% of patients. 1 Magnetic resonance imaging is the most sensitive and specific diagnostic imaging modality. The classic changes seen on magnetic resonance imaging are increased signal intensity lesions on T2-weighted, diffusion weighted and FLAIR images especially in the temporal lobe of the brain.
CSF polymerase chain reaction for HSV DNA is the most sensitive (495%) and specific (490%) test for diagnosis of HSE. 4 Rarely, it may be false negative in the first few days of infection onset and should be repeated if the clinical suspicion for HSE is high.
Treatment with intravenous acyclovir (10 mg/kg every 8 h) should be started without any significant delay if the diagnosis of HSE is suspected and should be continued for 2-3 weeks. 5 Even with the initiation of early treatment, two-thirds of the surviving patients will have some longterm neurological deficits. 
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The innate immune system primarily mediates HSV infection, and humoral and cell-mediated immune responses are considered to be less important in its pathogenesis. This may partially explain the relative rarity of severe HSV infections in allogeneic HCT recipients, even among patients with protracted graft-versus-host disease. HSV activates innate immunity through toll-like receptor dependent mechanisms, especially through toll-like receptor-2, -3 and -9 that are expressed in the glial and neuronal cells. 6, 7 Guidelines recommend routine acyclovir prophylaxis for HSV seropositive HCT recipients, starting at the initiation of conditioning regimen and continuing till engraftment occurs or until resolution of mucositis, whichever occurs later. 8 There is no published experience to suggest that the presentation of HSE in allogeneic HCT recipients is atypical from what is seen in the immunocompetent host and our patient was a 'text-book' case of HSE. There should be a high index of suspicion for HSE in allogeneic HCT recipients who present with suggestive neurological symptoms.
